Irbesartan vs Trastuzumab
Irbesartan vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Irbesartan and Trastuzumab.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Irbesartan — 11-15 hours; Trastuzumab — 28 days.
Chemical Properties
Molecular Formula: Irbesartan — C25H28N6O.
Molecular Weight: Irbesartan — 428.5320 g/mol.
Type: Irbesartan — Small molecule; Trastuzumab — Antibody.